HYAFLEX is recommended for the treatment of joint pain or stiffness resulting from degenerative or post-traumatic knee osteoarthritis, as a replacement for or together with a traditional non-pharmacological therapy or analgesic therapy.
All of the synovial joints, notably the weight-bearing joints that support the weight of the body, contain viscoelastic hyaluronic acid. This substance has lubricating properties and properties that offer protection against shocks. Reduction of stress on the cartilage allows it to regenerate and consequently slows the progression of the osteoarthritis.
The hyaluronic acid (molecular mass 650 ~ 1200 kDa) contained in HYAFLEX is a natural polysaccharide derived from microorganisms (Streptococcus zooepidemicus), and then purified.
HYAFLEX is injected into the articular cavity to restore synovial fluid.
We recommend 3 injections per treatment, at a rate of one per week.
The dosage and number of injections will depend on the severity of the patient’s symptoms.
The effects of the treatment can last for at least 6 months after the series of 3 HYAFLEX injections.
Single-use glass syringe containing 2.5 ml of the product in sterile packaging.
1 ml of HYAFLEX contains 10.0 mg of sodium hyaluronate dissolved in a physiological saline solution (pH between 6.8 and 7.8).
Boxes of 1, 3 and 25 syringes.
Sterile injectable medical device.
HYAFLEX must be administered by a doctor. CE 0086
NC2 helps ensure cartilage function*.
USA300 contains substances derived from soya.
A unique combination for healthy cartilage*.
HYAFLEX FORTE is recommended for the treatment of joint pain.
Mobilityl helps keep joints supple*.
No result was found for your search